GSK PLC (GSK)
41.05
+0.14
(+0.34%)
USD |
NYSE |
Apr 26, 10:00
GSK Total Long Term Debt (Quarterly): 21.42B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 21.42B |
September 30, 2023 | 25.42B |
June 30, 2023 | 27.09B |
March 31, 2023 | 25.89B |
December 31, 2022 | 24.18B |
September 30, 2022 | 24.70B |
June 30, 2022 | 26.82B |
March 31, 2022 | 43.78B |
December 31, 2021 | 31.25B |
September 30, 2021 | 34.38B |
June 30, 2021 | 35.27B |
March 31, 2021 | 36.04B |
December 31, 2020 | 35.48B |
September 30, 2020 | 36.34B |
June 30, 2020 | 39.01B |
March 31, 2020 | 39.59B |
December 31, 2019 | 38.36B |
September 30, 2019 | 40.62B |
June 30, 2019 | 42.40B |
March 31, 2019 | 41.42B |
December 31, 2018 | 32.99B |
September 30, 2018 | 36.10B |
June 30, 2018 | 36.69B |
March 31, 2018 | 24.47B |
December 31, 2017 | 23.00B |
Date | Value |
---|---|
September 30, 2017 | 25.56B |
June 30, 2017 | 24.55B |
March 31, 2017 | 22.88B |
December 31, 2016 | 23.01B |
September 30, 2016 | 25.10B |
June 30, 2016 | 26.36B |
March 31, 2016 | 24.40B |
December 31, 2015 | 24.54B |
September 30, 2015 | 25.05B |
June 30, 2015 | 27.00B |
March 31, 2015 | 27.34B |
December 31, 2014 | 29.10B |
September 30, 2014 | 30.79B |
June 30, 2014 | 30.06B |
March 31, 2014 | 28.69B |
December 31, 2013 | 29.95B |
September 30, 2013 | 29.76B |
June 30, 2013 | 28.42B |
March 31, 2013 | 29.36B |
December 31, 2012 | 29.45B |
September 30, 2012 | 28.38B |
June 30, 2012 | 26.74B |
March 31, 2012 | 23.48B |
December 31, 2011 | 22.81B |
September 30, 2011 | 23.52B |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
21.42B
Minimum
Dec 2023
43.78B
Maximum
Mar 2022
33.05B
Average
35.27B
Median
Jun 2021
Total Long Term Debt (Quarterly) Benchmarks
AstraZeneca PLC | 27.49B |
Haleon PLC | 11.87B |
Novo Nordisk A/S | 3.159B |
Pfizer Inc | 70.84B |
Sanofi SA | 18.12B |